SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $235,529 | +14.3% | 1,943 | +7.9% | 0.00% | 0.0% |
| Q2 2023 | $206,135 | -4.4% | 1,800 | +15.1% | 0.00% | 0.0% |
| Q1 2023 | $215,565 | +2.6% | 1,564 | -41.9% | 0.00% | +100.0% |
| Q1 2022 | $210,000 | 0.0% | 2,693 | +15.5% | 0.00% | 0.0% |
| Q4 2021 | $210,000 | -22.8% | 2,332 | -33.4% | 0.00% | -50.0% |
| Q2 2021 | $272,000 | +11.9% | 3,499 | +7.4% | 0.00% | 0.0% |
| Q1 2021 | $243,000 | -52.9% | 3,257 | +7.6% | 0.00% | -50.0% |
| Q4 2020 | $516,000 | +15.2% | 3,027 | -5.1% | 0.00% | 0.0% |
| Q3 2020 | $448,000 | -12.3% | 3,191 | +0.2% | 0.00% | -20.0% |
| Q2 2020 | $511,000 | +61.7% | 3,184 | -1.5% | 0.01% | +25.0% |
| Q1 2020 | $316,000 | – | 3,232 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |